January 11, 2022: Dr. Diana Zuckerman, president of NCHR, speaks in favor of CMS decision to limit coverage of the Alzheimer’s drug, Aduhelm.
Read More »On Health Policy
NCHR Comments on CMS’s Proposed Decision Memo on Screening for Lung Cancer with Low Dose Computed Tomography (LDCT)
December 17, 2021. We agree that former smokers would benefit from a higher rate of LDCT screening. However, we are concerned with several major aspects of the Proposed Decision Memo’s discussion of Counseling and Shared Decision-Making.
Read More »GDUFA III Statement of Dr. Diana Zuckerman, President of the National Center for Health Research
November 16, 2021: There are issues of safety and effectiveness in the GDUFA III Commitment letter.
Read More »NCHR’s Comments on USPSTF’s Draft Recommendation Statement on Screening for Eating Disorders
November 15, 2021: We strongly agree with the USPSTF’s “I” grade recommendation that there is insufficient evidence in order to assess the benefits and risks of universal screening for eating disorders in asymptomatic adolescents and adults.
Read More »NCHR’s Comments at EPA’s 2021 CHPAC Meeting
November 2, 2021: We strongly urge the EPA to conduct research on how currently used materials for artificial turf and playgrounds can pose risks to the health of the children who play on them, and to develop standards to regulate the safety of these materials.
Read More »